Radiopharmaceuticals
18F FDG
18F-JK-PSMA7
Gallium-68 (Ge-68/Ga-68)
Terbium-161 (Tb-161)
18F FDG
18F FDG is a radiopharmaceutical used in PET for the diagnosis of cancer and neurological diseases.
18F-JK-PSMA7
18F-PSMA-7 is a radiopharmaceutical used in PET for the diagnosis of prostate cancer.
Gallium-68 (Ge-68/Ga-68)
Gallium-68 (Ga-68) is a radiopharmaceutical used in PET for tumor diagnosis.
Terbium-161 (Tb-161)
Terbium-161 is a radionuclide used in targeted radionuclide therapy of various types of tumors.
18F FDG is a radiopharmaceutical used in PET for the diagnosis of cancer and neurological diseases.
18F-PSMA-7 is a radiopharmaceutical used in PET for the diagnosis of prostate cancer.
Gallium-68 (Ga-68) is a radiopharmaceutical used in PET for tumor diagnosis.
Terbium-161 is a radionuclide used in targeted radionuclide therapy of various types of tumors.
Radiopharmaceuticals
What are radiopharmaceuticals?
Radiopharmaceuticals are specialized drugs that contain radioactive isotopes and are used in diagnostics and therapy. These preparations enable precise monitoring and treatment of diseases, especially in the field of oncology, cardiology and neuromedicine.

Applications of radiopharmaceuticals:

Diagnostics
They are most often used for the detection and monitoring of cancer, cardiovascular diseases, neurological diseases and infections.

Theranostics
A combination of diagnostics and therapy that enables cancer treatment while simultaneously monitoring the effectiveness of therapy.

Radioligand therapy (RLT)
Radiopharmaceuticals are used to directly destroy cancer cells by targeting specific tumor tissues using a radioactive isotope.